Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology
Carregando...
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Autores
Citação
CLINICS, v.74, article ID e722, 7p, 2019
Resumo
OBJECTIVES: This study aimed to provide evidence for understanding how to treat osteoarthritis (OA) in our country. Therefore, it was necessary to match information and investigations related to the treatment of the disease from the three main types of specialists involved: physiatrists, orthopedists and rheumatologists. METHODS: The authors acted as a scientific advisory committee. From the initial discussions, a structured questionnaire was developed for use with a group of specialists on OA using the Delphi technique. The questionnaire was sent to 21 experts appointed by the authors, and the results obtained were critically analyzed and validated. RESULTS: The prevalence of OA was 33% in Brazil, corresponding to one-third of the individuals in the reference population, which included individuals over 25 years of age. Another significant finding was that most patients did not receive any form of treatment in the early stages of OA. CONCLUSION: The committee pointed to the need for early intervention and that the available medicinal resources can fulfil this important role, as is the case with SYSADOA treatments. Glucosamine-based medicinal products with or without chondroitin could also fulfill this need for early treatment. The other generated evidence and included investigations were then grouped together and are the subject of this publication.
Palavras-chave
Osteoarthritis, Osteoarthrosis, Surgical Treatment, Drug Therapy, Glucosamine, Chondroitin
Referências
- Berenbaum F, 2015, OSTEOARTHR CARTILAGE, V23, P1823, DOI 10.1016/j.joca.2015.09.012
- Brosseau L, 2000, J RHEUMATOL, V27, P1961
- Bruyere O, 2016, SEMIN ARTHRITIS RHEU, V45, pS3, DOI 10.1016/j.semarthrit.2015.11.010
- Bruyere O, 2014, SEMIN ARTHRITIS RHEU, V44, P253, DOI 10.1016/j.semarthrit.2014.05.014
- Coimbra Fernanda Ximenes, 2004, Rev. Bras. Reumatol., V44, P206, DOI 10.1590/S0482-50042004000300005
- de Rezende MU, 2013, ACTA ORTOP BRAS, V21, P120, DOI 10.1590/S1413-78522013000200010
- Dillon CF, 2006, J RHEUMATOL, V33, P2271
- Governo do Brasil, 2012, OST
- Grotle M, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-132
- Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177
- Hochberg MC, 2016, ANN RHEUM DIS, V75, P37, DOI 10.1136/annrheumdis-2014-206792
- Instituto Brasileiro de Geografia e Estatistica, 2008, PROJ POP BRAZ GEND A
- Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176
- Le T Kim, 2012, J Pain Res, V5, P23, DOI 10.2147/JPR.S27275
- Louati K, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000077
- Lozada CJ, 2017, OSTEOARTHRITIS
- Martel-Pelletier J, 2015, ANN RHEUM DIS, V74, P547, DOI 10.1136/annrheumdis-2013-203906
- McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003
- Mobasheri A, 2016, ANN PHYS REHABIL MED, V59, P333, DOI 10.1016/j.rehab.2016.07.004
- Natalo MA, 2010, DIGITAL MAGAZINE
- Oliveira JSP, 2008, INTRO AO METODO DELP
- Pavelka K, 2016, DRUG AGING, V33, P75, DOI 10.1007/s40266-016-0347-4
- Puenpatom RA, 2009, POSTGRAD MED, V121, P9, DOI 10.3810/pgm.2009.11.2073
- Rosales AD, 2014, ACTA ORTOP BRAS, V22, P136, DOI 10.1590/1413-78522014220300679
- Roubille C, 2015, SEMIN ARTHRITIS RHEU, V45, P257, DOI 10.1016/j.semarthrit.2015.05.001
- Sakellariou G, 2017, ANN RHEUM DIS, V76, P1484, DOI 10.1136/annrheumdis-2016-210815
- Sartori-Cintra AR, 2014, EINSTEIN-SAO PAULO, V12, P374, DOI 10.1590/S1679-45082014RB2912
- World Health Organization, 2003, TECHNICAL REPORT SER, V919
- Wu D, 2013, INT J CLIN PRACT, V67, P585, DOI 10.1111/ijcp.12115
- Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013